Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Direct Payment
$120,000.00
Quantifying Somatic Evolution for Colorectal Cancer Risk Prediction
FY 2025-26
Summary
Colorectal cancer (CRC) claims the lives of over 9,000 Canadians per year and incurs 3.5 billion dollars in direct healthcare costs. Finding cancer early leads to better patient outcomes. Canadian adults begin screening for colon cancer through colonoscopies starting at the age of 50. Colonoscopies can reliably detect tumours, yet it is invasive and expensive, thus done only in 10-year intervals. However, aggressive cancers can develop rapidly and be missed in between screening. To screen smarter, we need to find a way to identify individuals at high-risk for developing colon cancer and should be monitored more frequently while they are still healthy. However, the earliest changes in the colon that lead to cancer are not well understood.
Our lab has shown that in the blood, inflammation can cause cancer related DNA mutations to become more abundant, which raises the chance of developing acute myeloid leukemia. We believe a similar process happens in the colon, where cancer arises after a period of silent, cancer-predisposing changes in otherwise normal looking tissue. My project focuses on using tailored DNA sequencing assays to study the early patterns that occur in healthy-appearing colon tissue that signal higher risk for future cancer development. Using these findings, I will design a simple, low-cost test that can be added to routine colonoscopy procedures. This test will be able to examine an individual's normal colonic tissue and generate a score to estimate an individual's future risk for developing CRC.
Clearly defining a high-risk population for CRC screening benefits both individuals and the broader community. Knowing your risk for CRC while you are still healthy creates a clear path of action, which may include increasing the frequency of colonoscopies or making targeted changes to your lifestyle. For healthcare systems, resources can be focused on screening those who need it, lowering CRC cases and deaths while avoiding unnecessary costs.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
556146
Name
Gong Ling Xi
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Quantifying Somatic Evolution for Colorectal Cancer Risk Prediction
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cancer Detection; Colorectal Cancer; Genomics; Somatic Evolution
Abstract
Colorectal cancer (CRC) claims the lives of over 9,000 Canadians per year and incurs 3.5 billion dollars in direct healthcare costs. Finding cancer early leads to better patient outcomes. Canadian adults begin screening for colon cancer through colonoscopies starting at the age of 50. Colonoscopies can reliably detect tumours, yet it is invasive and expensive, thus done only in 10-year intervals. However, aggressive cancers can develop rapidly and be missed in between screening. To screen smarter, we need to find a way to identify individuals at high-risk for developing colon cancer and should be monitored more frequently while they are still healthy. However, the earliest changes in the colon that lead to cancer are not well understood.
Our lab has shown that in the blood, inflammation can cause cancer related DNA mutations to become more abundant, which raises the chance of developing acute myeloid leukemia. We believe a similar process happens in the colon, where cancer arises after a period of silent, cancer-predisposing changes in otherwise normal looking tissue. My project focuses on using tailored DNA sequencing assays to study the early patterns that occur in healthy-appearing colon tissue that signal higher risk for future cancer development. Using these findings, I will design a simple, low-cost test that can be added to routine colonoscopy procedures. This test will be able to examine an individual's normal colonic tissue and generate a score to estimate an individual's future risk for developing CRC.
Clearly defining a high-risk population for CRC screening benefits both individuals and the broader community. Knowing your risk for CRC while you are still healthy creates a clear path of action, which may include increasing the frequency of colonoscopies or making targeted changes to your lifestyle. For healthcare systems, resources can be focused on screening those who need it, lowering CRC cases and deaths while avoiding unnecessary costs.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gong, Ling Xi
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~